Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.


Manoj J. Mammen, MD, has co-authored international guidelines — jointly published in Critical Care Medicine and Intensive Care Medicine — for the management of critically ill adults with coronavirus disease (COVID-19).


UB and Roswell Park Comprehensive Cancer Center have launched a collaborative clinical trial that will make a new treatment option available to local patients diagnosed with COVID-19. 


The Hepatology Clinic at the Erie County Medical Center (ECMC) continues to gain national and international recognition for its unique approach and exceptional cure rate for hepatitis C.


The importance of the gathering needs to be balanced with potential consequences, especially if some family members are vulnerable and are at risk for a bad outcome if they become infected with the new coronavirus.



Lack of ventilators and PPE to protect staff will be the main obstacles to following guidelines, UB faculty member says.


Three Jacobs School of Medicine and Biomedical Sciences faculty members wrote a chapter in the book “Neurological Disorders and Imaging Physics, Volume 3: Application to Autism Spectrum Disorders and Alzheimer’s.”

UBMD Physicians’ Group and its practices are continually monitoring the evolving COVID-19 situation and following the recommendations from the Centers for Disease Control and Prevention (CDC), New York State Department of Health and Erie County Department of Health.

University at Buffalo researchers have discovered a link between fats in the blood and problems with the arteries in multiple sclerosis (MS) patients.


UB medical residents, along with their faculty mentors, have dramatically reduced from 80% to 30% inappropriate PPI prescriptions at an urban academic medicine clinic in Buffalo.


Researchers have published the first study comparing brain changes among age-matched healthy controls and patients who have MS or other neurological diseases, including Alzheimer’s and Parkinson’s.